RAPP

NASDAQ · Equity

Rapport Therapeutics, Inc. Common Stock

US Healthcare Biotechnology

Latest week
29 May 2026
Close
39.500000
Fair value
21.611602
Expectation
Positive 59.04%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
39.50
12-Week Change
41.88%
Trend Signal
Active
Expectation
Positive 59.04%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
28.39
Market Dynamics
0.82

Over the latest 12 completed weeks ending 2026-05-29, RAPP rose 41.88%, moving from 27.84 to 39.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 28.39 and has softened across the 12-week window. Market Dynamics is 0.82 on the latest week. Expectation is positive at 59.04%.